Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.780
+0.150 (3.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 203 employees as of December 31, 2023. The number of employees decreased by 87 or -30.00% compared to the previous year.
Employees
203
Change (1Y)
-87
Growth (1Y)
-30.00%
Revenue / Employee
$940,187
Profits / Employee
-$80,729
Market Cap
278.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Zynex | 1,100 |
Amylyx Pharmaceuticals | 384 |
COMPASS Pathways | 186 |
ProQR Therapeutics | 157 |
C4 Therapeutics | 145 |
Foghorn Therapeutics | 116 |
Sanara MedTech | 108 |
VNDA News
- 1 day ago - Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity - Seeking Alpha
- 1 day ago - Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera - PRNewsWire
- 5 days ago - Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc. - Business Wire
- 5 weeks ago - Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences - PRNewsWire
- 6 weeks ago - Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst - Benzinga
- 7 weeks ago - Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024 - PRNewsWire